【药物名称】JTC-801
化学结构式(Chemical Structure):
参考文献No.40645
标题:Amide derivs. and nociceptin antagonists
作者:Shinkai, H.; Yamada, H.; to, T. (Japan Tobacco Inc.)
来源:EP 1072263; JP 1999335355; WO 9948492
合成路线图解说明:

Bromination of methyl toluate (I) with N-bromosuccinimide and benzoyl peroxide (Bz2O2) in refluxing CCl4 gives alpha-bromo-o-toluate (II), which is coupled with phenolic derivative (III) by means of K2CO3 in DMF to provide phenoxy derivative (IV). Saponification of the methyl ester group of (IV) by treatment with KOH in refluxing EtOH affords carboxylic acid (V), which is then converted into the desired compound via the corresponding acid chloride obtained by reaction with oxalyl chloride in CHCl3, followed by coupling with 4,6-diamino-2-methylquinoline (XII) by means of pyridine. Quinoline (XII) can be obtained as follows: Condensation of 4-aminoacetanilide (VII) with methyl acetoacetate (VIII) by heating in MeOH affords crotonate (IX), which is then subjected to cyclization in refluxing Dowtherm A to provide hydroxy quinoline (X). Methylation of (X) with dimethyl sulfate in refluxing toluene gives methoxy quinoline (XI), whose methoxy group is converted into an amino group with ammonium acetate and whose acetyl group is finally removed by hydrolysis with HCl.

合成路线图解说明:

5-Nitroisatin (VIII) is condensed with acetone in the presence of aqueous ammonia in an autoclave at 100 C to produce the quinolinecarboxamide (IX). Subsequent Hofmann rearrangement of (IX) with sodium hypochlorite produces the 4-amino quinoline (X). The nitro group of (X) is then reduced by catalytic hydrogenation over Pd/C to give the diaminoquinoline (VII).

合成路线图解说明:

Radical bromination of methyl ortho-toluate (XI) with N-bromosuccinimide in the presence of benzoyl peroxide affords the 2-(bromomethyl)benzoate (XII). This is then condensed with 4-ethylphenol (XIII) to furnish ether (XIV). Alkaline hydrolysis of the methyl ester group of (XIV) provides acid (XV), which is further activated as the corresponding acid chloride (XVI) with oxalyl chloride in chloroform. Finally, condensation of acid chloride (XVI) with the diaminoquinoline (VII) gives rise to the title compound.

参考文献No.601600
标题:4-Aminoquinolones: Novel nociceptin antagonists with analgesics activity
作者:Shinkai, H.; Ito, T.; Iida, T.; Kitao, Y.; Yamada, H.; Uchida, I.
来源:J Med Chem 2000,43(24),4667
合成路线图解说明:

Bromination of methyl toluate (I) with N-bromosuccinimide and benzoyl peroxide (Bz2O2) in refluxing CCl4 gives alpha-bromo-o-toluate (II), which is coupled with phenolic derivative (III) by means of K2CO3 in DMF to provide phenoxy derivative (IV). Saponification of the methyl ester group of (IV) by treatment with KOH in refluxing EtOH affords carboxylic acid (V), which is then converted into the desired compound via the corresponding acid chloride obtained by reaction with oxalyl chloride in CHCl3, followed by coupling with 4,6-diamino-2-methylquinoline (XII) by means of pyridine. Quinoline (XII) can be obtained as follows: Condensation of 4-aminoacetanilide (VII) with methyl acetoacetate (VIII) by heating in MeOH affords crotonate (IX), which is then subjected to cyclization in refluxing Dowtherm A to provide hydroxy quinoline (X). Methylation of (X) with dimethyl sulfate in refluxing toluene gives methoxy quinoline (XI), whose methoxy group is converted into an amino group with ammonium acetate and whose acetyl group is finally removed by hydrolysis with HCl.

合成路线图解说明:

Radical bromination of methyl ortho-toluate (XI) with N-bromosuccinimide in the presence of benzoyl peroxide affords the 2-(bromomethyl)benzoate (XII). This is then condensed with 4-ethylphenol (XIII) to furnish ether (XIV). Alkaline hydrolysis of the methyl ester group of (XIV) provides acid (XV), which is further activated as the corresponding acid chloride (XVI) with oxalyl chloride in chloroform. Finally, condensation of acid chloride (XVI) with the diaminoquinoline (VII) gives rise to the title compound.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us